SCHEMBL10083333

SCHEMBL10083333

O=C(O)C1(c2cnc3ccccc3c2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.63
AKR1C2 P52895 1/20 0.63
MGAM O43451 1/20 0.53
RAB9A P51151 3/20 0.47
CNR2 P34972 2/20 0.46
AKR1C1 Q04828 1/20 0.46
KDR P35968 1/20 0.46
KDM4E B2RXH2 3/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAP4K4 O95819 1/20 0.43
CSNK1G2 P78368 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
MKNK2 Q9HBH9 1/20 0.43
MAP4K5 Q9Y4K4 1/20 0.43
ITGA4 P13612 1/20 0.43
ITGB7 P26010 1/20 0.43
CFTR P13569 1/20 0.43
CYP1A2 P05177 1/20 0.42
PDGFRB P09619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2037389 0.80 AKR1C3 (0.55) AKR1C3AKR1C2RAB9AKDM4ENPC1
SCHEMBL349729 0.75 AKR1C1 (0.53) AKR1C3AKR1C2AKR1C1
SCHEMBL8138956 0.75 FASN (0.46) AKR1C3AKR1C2MGAMRAB9ACNR2
SCHEMBL10083307 0.74 ALDH1A1 (0.50) AKR1C3AKR1C2MGAMRAB9AAKR1C1
SCHEMBL9721851 0.74 NPSR1 (0.47) AKR1C3AKR1C2MGAMRAB9ACNR2
SCHEMBL28296424 0.73 CYP1A2 (0.47) AKR1C3AKR1C2MGAMRAB9ACNR2
SCHEMBL12505005 0.72 MGAM (0.52) AKR1C3AKR1C2MGAMRAB9ACNR2
SCHEMBL6391 0.71 AKR1C1 (0.83) RAB9AAKR1C1
SCHEMBL31016196 0.71 AKR1C1 (0.83) RAB9AAKR1C1
SCHEMBL7203556 0.71 CHRNB2 (0.48) AKR1C3AKR1C2MGAMRAB9ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-9303027-B2 Kappa opioid receptor agonists DR. REDDY'S LABORATORIES LTD. (IN) 2016-04-05 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES, INC. (US) 2013-11-14 US disclosed
WO-2012012410-A2 KAPPA OPIOID RECEPTOR AGONISTS DR. REDDY'S LABORATORIES LTD. (IN) 2012-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130303525-A1 KAPPA OPIOID RECEPTOR AGONISTS OPRK1, OPRL1, OPRD1 AKR1C3 257/4885AKR1C2 580/4885MGAM 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.